Michael Kaseta
Vermögen: 8 Mio $ am 31.05.2026
Vermögen: 8 Mio $ am 31.05.2026
Michael Kaseta is currently Director at Bryn Pharma LLC since 2023, Independent Director at Heron Therapeutics, Inc. since 2024, Chief Financial & Operating Officer at Liquidia Corp.
since 2020, and Chief Financial & Operating Officer at Liquidia Technologies, Inc. since 2020.
Former roles include Independent Director at Alimera Sciences, Inc. from 2023 to 2024, Chief Financial Officer-Sanofi North America at Sanofi from 2015 to 2016, Chief Financial Officer at Aerami Therapeutics, Inc. from 2019 to 2020, and Chief Financial & Accounting Officer at Old API Wind-down Ltd. from 2018 to 2019.
Education includes undergraduate studies at James Madison University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0.15% | 23.05.2026 | 130’442 ( 0.15% ) | 8 Mio $ | 31.05.2026 |
| 14.04.2026 | 29’787 ( 0.02% ) | 25 915 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LIQUIDIA CORPORATION | Finanzdirektor/CFO | 30.11.2020 |
| HERON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 04.11.2024 |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Direktor/Vorstandsmitglied | 02.05.2023 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Finanzdirektor/CFO | 20.08.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| ALIMERA SCIENCES, INC. | Direktor/Vorstandsmitglied | 16.09.2024 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Finanzdirektor/CFO | 01.11.2020 |
| OLD API WIND-DOWN LTD. | Finanzdirektor/CFO | 01.01.2019 |
| SANOFI | Corporate Officer/Principal | 01.09.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Alimera Sciences, Inc.
Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
James Madison University
James Madison University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Old API Wind-down Ltd.
Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen